Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-08-18

Clinical Trial Update: Ginkgo Biloba Extract and the Insulin Resistance Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluated Ginkgo Biloba Extract for insulin resistance in adults with Type 2 Diabetes Mellitus, covering Phase 1 and Phase 2; the study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ginkgo biloba extract (Ginkgo biloba extract)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Type 2 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED